Skip to main content
. 2019 Oct 20;1:91–97. doi: 10.1016/j.prdoa.2019.08.006

Table 2.

Baseline characteristics of PUC cohort, PDD converters vs. nonconverters.

Converted to dementia
(n = 66)
Did not convert
(n = 250)
p-value
Age, years
 Mean (SD) 70.7 (8.4) 65.4 (8.5) <0.0001
 Range 50.1–90.1 43.04–89.2
Education, years
 Mean (SD) 16.0 (2.6) 16.0 (2.5) 0.906
 Range 12–20 8–20
Sex
 n (%) male 51 (77.3) 159 (63.6) 0.036
Follow-up time, years
 Mean (SD) 3.5 (1.8) 3.8 (1.8) 0.278
 Range 1.0–7.0 0.8–8.0
Number of visits
 Mean (SD) 2.8 (1.0) 3.0 (1.1) 0.190
 Range 2–6 2–6
Disease duration, years
 Mean (SD) 8.5 (5.7) 7.6 (5.7) 0.275
 Range 1–24 0–24
LEDD, mg/d
 Mean (SD) 678.5 (507.0) 559.2 (472.9) 0.074
 Range 0–2876 0–2972
Geriatric Depression Scale
 Mean (SD) 6.0 (1.6) 5.6 (1.5) 0.019
 Range 4–12 2–12
MDS-UPDRS-III
 Mean (SD) 26.5 (10.6) 23.5 (11.3) 0.052
 Range 10–57 3–60
Modified Hoehn & Yahr
 Median 2.25 2 0.004
 Range 1–4 1–5
APOE ε4 allele
 n (%) 14 (21.9) 54 (22.0) 0.990
GBA variant
 n (%) 6 (9.1) 21 (8.4) 0.865
MoCA
 Mean (SD) 23.7 (2.4) 25.7 (2.5) <0.0001
 Range 17–30 18–30
DRS-2
 Mean (SD) 136.4 (4.6) 138.2 (5.1) 0.012
 Range 125–144 103–144
MMSE
 Mean (SD) 27.9 (1.5) 28.4 (1.6) 0.031
 Range 24–30 23–30

Abbrev: APOE, apolipoprotein; DRS-2, Mattis Dementia Rating Scale; GBA, glucocerebrosidase gene; LEDD, levodopa equivalent daily dose; MDS-UPDRS, Movement Disorders Society- sponsored Unified Parkinson's Disease Rating Scale revision; MMSE, Mini Mental State Examination; MoCA, Montreal Cognitive Assessment; PDD, Parkinson's disease dementia; PUC, Pacific Udall Center; SD, standard deviation.

Groups compared using t-tests for continuous variables (age, education, disease duration, LEDD, Geriatric Depression Scale, MDS-UPDRS, MMSE, MoCA, DRS-2), chi-square for categorical variables (sex), and Kruskal-Wallis one-way analysis of variance for ordinal data (Modified Hoehn and Yahr).